These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18157384)

  • 21. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.
    Chaplin JE; Kriström B; Jonsson B; Hägglöf B; Tuvemo T; Aronson AS; Dahlgren J; Albertsson-Wikland K
    Horm Res Paediatr; 2011; 75(4):291-303. PubMed ID: 21304250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of red blood cell indices in growth-hormone-treated children.
    Valerio G; Di Maio S; Salerno M; Argenziano A; Badolato R; Tenore A
    Horm Res; 1997; 47(2):62-6. PubMed ID: 9030969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
    Çamtosun E; Şıklar Z; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2018 Jul; 10(3):247-255. PubMed ID: 29553045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
    Kivitz A; Cohen S; Dowd JE; Edwards W; Thakker S; Wellborne FR; Renz CL; Segurado OG
    Clin Ther; 2006 Oct; 28(10):1619-29. PubMed ID: 17157117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid cardiovascular effects of growth hormone treatment in short prepubertal children: impact of treatment duration.
    Nygren A; Sunnegårdh J; Teien D; Jonzon A; Björkhem G; Lindell S; Albertsson-Wikland K; Kriström B
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):877-84. PubMed ID: 22651572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency.
    Land C; Blum WF; Stabrey A; Schoenau E
    Eur J Endocrinol; 2005 May; 152(5):727-33. PubMed ID: 15879358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Status of long-acting-growth hormone preparations--2015.
    Høybye C; Cohen P; Hoffman AR; Ross R; Biller BM; Christiansen JS;
    Growth Horm IGF Res; 2015 Oct; 25(5):201-6. PubMed ID: 26187188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
    Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO
    Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
    Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A; Audí L; Fernández-Cancio M; Yeste D; Gussinye M; Campos A; Albisu MA; Clemente M; Bel J; Nosás R; Rabanal M; Del Pozo C; Gómez JM; Mesa J;
    Horm Res Paediatr; 2013; 79():145-56. PubMed ID: 23548791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels.
    Roth EM; Bujas-Bobanovic M; Louie MJ; Cariou B
    Clin Ther; 2015 Sep; 37(9):1945-1954.e6. PubMed ID: 26278513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to growth hormone therapy: a practical approach.
    Bozzola M; Pagani S; Iughetti L; Maffeis C; Bozzola E; Meazza C
    Horm Res Paediatr; 2014; 81(5):331-5. PubMed ID: 24714410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency.
    Kawai M; Momoi T; Yorifuji T; Yamanaka C; Sasaki H; Furusho K
    J Pediatr; 1997 Feb; 130(2):205-9. PubMed ID: 9042121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone therapy: emerging dilemmas.
    Laron Z
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):364-73. PubMed ID: 21972776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.